Menu mobile menu

Staff

Dr. Mostafa Samak

Postdoctoral Scientist

Laboratory Animal Science

+49 551 3851-125

MSamak(at)dpz.eu

B1.13

Kellnerweg 4
37077 Göttingen

  • Microvascular dysfunction in diabetes mellitus

  • Diabetic cardiomyopathy

  • Endothelial biology

Education

  • Ph.D. in Molecular Medicine - Georg-August University of Göttingen

  • Master of Science in Molecular Medicine - Georg-August University of Göttingen

  • Bachelor of Science in Pharmaceutical Sciences - Helwan University - Egypt

  • German Centre for Cardiovascular Research
  • German Cardiac Society
  • European Vascular Biology Organization (EVBO)

 

  1. Samak M et al.: Dysregulation of Krüppel-like factor 2 and myocyte enhancer factor 2D drive cardiac microvascular inflammation in diabetes. Int J Mol Sci. 2023; 24(3):2482. doi: 10.3390/ijms24032482.

  2. Samak M et al.: Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes. Biomedicines, 2021 Dec 28; 10(1), 58. doi: 10.3390/biomedicines10010058.

  3. Samak M and Hinkel R: Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects. Cells, 2019 Nov 27; 8(12):1530. doi: 10.3390/cells8121530.

  4. Samak M et al.: Total Arterial Revascularization: Bypassing Antiquated Notions to Better Alternatives for Coronary Artery Disease. Med Sci Monit Basic Res, 2016 Oct 4; 22:107-114. doi: 10.12659/msmbr.901508.

  5. Samak M et al.:  Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis. Med Sci Monit Basic Res, 2016 Jul 23; 22:75-79. doi: 10.12659/MSMBR.900437.

  6. Samak M et al.: Past and Present of Total Artificial Heart Therapy: A Success Story. Med Sci Monit Basic Res, 2015 Sep 7; 21:183-90. doi: 10.12659/MSMBR.895418.

  7. Fatullayev J*, Samak M* et al.: Non-Heart Beating Donor Heart Transplantation: Breaking the Taboo. Med Sci Monit Basic Res, 2015 Jul 15; 21:153-6. doi: 10.12659/MSMBR.894985. *Equal contribution

  8. Fatullayev J, Samak M et al.: Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Forseen is a Danger Avoided. Med Sci Monit Basic Res, 2015 Jul 1; 21:141-144.  doi: 10.12659/MSMBR.894840.

Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes.

Download (8 MB)

Back to overview